Induction therapy in patients with metastatic colorectal cancer

Seminars in Oncology

Volumn 30, Issue 4 SUPPL. 12, 2003, Pages 25-29

  Venook, Alan P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; FLUOROPYRIMIDINE; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HEPATIC ARTERY; HEPATOBILIARY DISEASE; HUMAN; INOPERABLE CANCER; LIVER METASTASIS; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT PLANNING; TUMOR VOLUME;

EID: 0141789573     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(03)00331-2     Document Type: Conference Paper

References (12)

1. Venook AP: Update on hepatic intra-arterial chemotherapy. Oncology 11:947-957, 1997
2. Schwesinger WH: Conference report: Evolving techniques for the treatment of hepatic metastases. Chicago, IL, October 22-27, 2000. Medscape Surgery 3, 2001. Available at http://www.medscape.com/viewarticle/408762 (accessed May 22, 2003)
3. Sturgeon CM, Helton WS, Espat NJ: Hepatic arterial infusion chemotherapy for hepatic colorectal cancer metastases. Hosp Physician 38:61-66, 2002
4. Kemeny N, Huang Y, Cohen AM, et al: Hepatic arterial infusion chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039-2048, 1999
5. Ellis LM, Chase J, Patt Y, et al: Hepatic arterial infusion chemotherapy for colorectal cancer metastasis to the liver. In Curley SA (ed): Diagnosis and Treatment of Hepatobiliary Cancers. New York, NY, Springer-Verlag, 1998, pp 150-172
6. Chang AE, Schneider PD, Sugarbaker PH, et al: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685-693, 1987
7. Hohn DC, Stagg RJ, Friedman MA, et al, for the Northern Oncology Group Trial: A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver. J Clin Oncol 7:1646-1654, 1989
8. Martin JK Jr, O'Connell MJ, Wieand HS, et al: Intraarterial floxuridine vs. systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 125:1022-1027, 1990
9. Meta-Analysis Group in Cancer: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Natl Cancer Inst 88:252-258, 1996
10. Kemeny NE, Niedzwiecki, Hollis DR, et al: Hepatic arterial infusion (HIA) versus systemic therapy for hepatic metastases from colorectal cancer; a CALGB randomized trial of efficacy, quality of life (QOL), cost effectiveness, and molecular markers. Proc Am Soc Clin Oncol 2:252, 2003 (abstr 1010)
11. Adson MA: Resection of liver metastases - When is it worthwhile? World J Surg 11:511-520, 1987
12. Adam R, Avisar E, Ariche A, et al: Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases. Ann Surg Oncol 8:347-353, 2001